Repair of HCMV-Induced DNA Damage in Infected Cells
修复受感染细胞中 HCMV 诱导的 DNA 损伤
基本信息
- 批准号:7155531
- 负责人:
- 金额:$ 24.45万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2002
- 资助国家:美国
- 起止时间:2002-12-15 至 2008-11-30
- 项目状态:已结题
- 来源:
- 关键词:AffectAntibodiesApoptosisBiological AssayBirthBlindnessCell CycleCell Cycle ProteinsCellsChromosomal BreaksChromosomesChromosomes, Human, Pair 1Comet AssayComplexCongenital AbnormalityCoupledCytogeneticsCytomegalovirusDNADNA DamageDNA RepairDNA SequenceDataDevelopmentEnvironmentFibroblastsFluorescent in Situ HybridizationGenomeGenus CapraGoatHeadHealedIn VitroInfantInfectionLearning DisabilitiesLifeLiteratureLocalizedMental RetardationMethodsMicrocephalyMitoticMonitorMorbidity - disease rateNervous System TraumaNeuraxisNeuronsNewborn InfantNonhomologous DNA End JoiningNuclearPhasePopulationPositioning AttributeProtein p53ProteinsPulsed-Field Gel ElectrophoresisTailTechniquesTestingThinkingTimeUltraviolet RaysViralViral AntigensViral ProteinsVirusWorkcell motilitycell typeclinically relevantcongenital infectiondeafnessdimerhealinghearing impairmenthuman H2AX proteinmortalityprotein expressionrelating to nervous systemrepairedresponsetissue culture
项目摘要
Human Cytomegalovirus (HCMV) is the major viral cause of birth defects, infecting 1-2% of all newborns
annually. Approximately 5-10% of these congenitally infected infants will manifest signs of serious
neurological damage at birth, which can include deafness, blindness, mental retardation and microcephaly.
Another 10-15% will develop sensori-neural hearing loss and/or learning disabilities within the first 10 years
of life. Our long-term goat is to understand the mechanism behind the development of morbidity and
mortality in infants congenitally infected with HCMV. Over the last several years we have studied the
interaction of HCMV with the cell cycle and DNA repair machinery of the permissively infected cell. We have
discerned that HCMV sequesters many key regulatory and repair proteins into its viral replication centers.
However, it appears to partition the components of several complexes so that all the proteins are present
within the replication centers, but not all are available to the cellular genome. We have also determined that
HCMV can induce specific damage on chromosome 1 during S-phase.
When coupled with the literature regarding nonspecific damage induced at late times post infection our
data more clearly highlights the genotoxic effects of HCMV. We hypothesize that long-term detrimental
consequences to the cellular genome may occur if 1) the initial specific damage is propagated or 2) damage
incurred at late times post infection is not repaired due to sequestration of the repair machinery. To test our
hypothesis, we propose three specific aims. First, we will thoroughly define the parameters of chromosome
lq breakage in HCMV-infected cells with regard to rapidity of induction and cell cycle phase at time of
infection. We think it is imperative that our results be moved into more clinically relevant cell types, especially
cells of neural lineage, as these are the cells most severely affected by the virus during congenital infection.
Second, we also will determine the consequences of chromosome 1 damage in these clinically relevant
cells, and whether in a semi-permissive environment we can observe propagation of the chromosome 1
damage instead of healing of the break or movement of the cell toward apoptosis. Lastly, we will
characterize the ability of HCMV-infected cells to repair exogenously introduced damage at late times post
infection, after viral replication centers are assembled.
人类巨细胞病毒(HCMV)是导致出生缺陷的主要病毒原因,感染了1-2%的新生儿
每年一次。这些先天感染的婴儿中大约有5%-10%会表现出严重的
出生时的神经损伤,可能包括耳聋、失明、智力低下和小头畸形。
另有10%-15%的人将在头10年内发展为感觉神经性听力损失和/或学习障碍
生活的一部分。我们的长远目标是了解发病和发病背后的机制。
先天性感染巨细胞病毒的婴儿死亡率。在过去的几年里,我们研究了
巨细胞病毒与允许感染细胞的细胞周期和DNA修复机制的相互作用。我们有
发现HCMV将许多关键的调节和修复蛋白隔离到其病毒复制中心。
然而,它似乎分割了几个复合体的成分,使所有的蛋白质都存在
在复制中心内,但不是所有的都可用于细胞基因组。我们还确定,
人巨细胞病毒可在S期引起1号染色体的特异性损伤。
当结合关于感染后晚期引起的非特异性损伤的文献时,我们的
数据更清楚地突出了人巨细胞病毒的遗传毒性效应。我们假设,从长远来看,
如果1)最初的特定损伤是传播的或2)损伤,则可能发生对细胞基因组的后果
感染后后期发生的感染由于修复机械的隔离而无法修复。测试我们的
假设,我们提出了三个具体目标。首先,我们将彻底定义染色体的参数
人巨细胞病毒感染细胞LQ断裂与诱导速度和细胞周期时相的关系
感染。我们认为,我们的结果必须转移到更多临床相关的细胞类型中,特别是
神经系细胞,因为这些细胞是先天感染期间受病毒影响最严重的细胞。
其次,我们还将确定1号染色体损伤在这些临床相关疾病中的后果
细胞,以及在半允许的环境中,我们是否可以观察到1号染色体的传播
损伤而不是愈合细胞的断裂或走向凋亡的运动。最后,我们将
人巨细胞病毒感染细胞在后期修复外源性损伤的能力
感染,在病毒复制中心组装后。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ELIZABETH A FORTUNATO其他文献
ELIZABETH A FORTUNATO的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ELIZABETH A FORTUNATO', 18)}}的其他基金
HCMV infection downregulates nidogen 1 and myelin protein zero
HCMV 感染下调 nidogen 1 和髓磷脂蛋白 0
- 批准号:
10219059 - 财政年份:2018
- 资助金额:
$ 24.45万 - 项目类别:
HCMV infection downregulates nidogen 1 and myelin protein zero
HCMV 感染下调 nidogen 1 和髓磷脂蛋白 0
- 批准号:
9982196 - 财政年份:2018
- 资助金额:
$ 24.45万 - 项目类别:
HCMV infection downregulates nidogen 1 and myelin protein zero
HCMV 感染下调 nidogen 1 和髓磷脂蛋白 0
- 批准号:
9757691 - 财政年份:2018
- 资助金额:
$ 24.45万 - 项目类别:
HUMAN CYTOMEGALOVIRUS INTERACTIONS WITH CELLULAR P53
人类巨细胞病毒与细胞 P53 的相互作用
- 批准号:
7959728 - 财政年份:2009
- 资助金额:
$ 24.45万 - 项目类别:
HUMAN CYTOMEGALOVIRUS INTERACTIONS WITH CELLULAR P53
人类巨细胞病毒与细胞 P53 的相互作用
- 批准号:
7720366 - 财政年份:2008
- 资助金额:
$ 24.45万 - 项目类别:
HUMAN CYTOMEGALOVIRUS INTERACTIONS WITH CELLULAR P53
人类巨细胞病毒与细胞 P53 的相互作用
- 批准号:
7609814 - 财政年份:2007
- 资助金额:
$ 24.45万 - 项目类别:
HUMAN CYTOMEGALOVIRUS INTERACTIONS WITH CELLULAR P53
人类巨细胞病毒与细胞 P53 的相互作用
- 批准号:
7381184 - 财政年份:2006
- 资助金额:
$ 24.45万 - 项目类别:
Repair of HCMV-Induced DNA Damage in Infected Cells
修复受感染细胞中 HCMV 诱导的 DNA 损伤
- 批准号:
6827854 - 财政年份:2002
- 资助金额:
$ 24.45万 - 项目类别:
Repair of HCMV-Induced DNA Damage in Infected Cells
修复受感染细胞中 HCMV 诱导的 DNA 损伤
- 批准号:
8197095 - 财政年份:2002
- 资助金额:
$ 24.45万 - 项目类别:
Repair of HCMV-Induced DNA Damage in Infected Cells
修复受感染细胞中 HCMV 诱导的 DNA 损伤
- 批准号:
8589573 - 财政年份:2002
- 资助金额:
$ 24.45万 - 项目类别:
相似海外基金
University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
- 批准号:
10073243 - 财政年份:2024
- 资助金额:
$ 24.45万 - 项目类别:
Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
- 批准号:
10752129 - 财政年份:2024
- 资助金额:
$ 24.45万 - 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
- 批准号:
2339201 - 财政年份:2024
- 资助金额:
$ 24.45万 - 项目类别:
Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
- 批准号:
MR/Y008693/1 - 财政年份:2024
- 资助金额:
$ 24.45万 - 项目类别:
Research Grant
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
- 批准号:
10076445 - 财政年份:2023
- 资助金额:
$ 24.45万 - 项目类别:
Grant for R&D
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
- 批准号:
23K14783 - 财政年份:2023
- 资助金额:
$ 24.45万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
- 批准号:
23KJ0394 - 财政年份:2023
- 资助金额:
$ 24.45万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Role of antibodies in hepatitis E virus infection
抗体在戊型肝炎病毒感染中的作用
- 批准号:
10639161 - 财政年份:2023
- 资助金额:
$ 24.45万 - 项目类别:
Defining the protective or pathologic role of antibodies in Post-Ebola Syndrome
定义抗体在埃博拉后综合症中的保护或病理作用
- 批准号:
10752441 - 财政年份:2023
- 资助金额:
$ 24.45万 - 项目类别:
Human CMV monoclonal antibodies as therapeutics to inhibit virus infection and dissemination
人 CMV 单克隆抗体作为抑制病毒感染和传播的治疗药物
- 批准号:
10867639 - 财政年份:2023
- 资助金额:
$ 24.45万 - 项目类别: